Robert J. Sommer, MD

Expertise in: 
Cardiovascular Disease
Board Certifications: 
Pediatric Cardiology, Pediatrics
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Cardiovascular Disease, Valvular Heart Disease, Adult Congenital Heart Disease (ACHD), Complex Congenital Heart Disease, Pediatric Congenital Heart Disease, Congenital Abnormalities, Atrial Septal Defect, Tetralogy of Fallot, Patent Ductus Arteriosus, Ventricular Septal Defect, Transcatheter Atrial Septal Defect, Valve Replacement, Atrial Fibrillation, Structural Heart Disease

Academic Appointments

  • Associate Professor of Medicine at CUMC

Administrative Titles

  • Director, Invasive Adult Congenital Heart Disease

Robert J. Sommer, MD is an Associate Professor of Medicine at the College of Physicians and Surgeons at Columbia University, and the Director, Invasive Adult Congenital Heart Disease and Invasive Structural Interventions at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. He is also affiliated with the Adult and Pediatrics Congenital Heart Program at St. Joseph's Hospital in Paterson, NJ. In addition to his Columbia site, Dr. Sommer has patient offices in Westchester County, New Jersey and Long Island.

Dr. Sommer has been caring for patients with congenital heart disease for nearly 30 years. In his current practice, he sees both Pediatric and Adult aged patients with birth defects of the heart. Echocardiography, electrocardiography, oximetry and transcranial Doppler evaluations are all available in his office. In addition to the office management of the patients with congenital heart disease, Dr. Sommer is a nationally recognized expert on the catheter assessment and intervention for congenital and structural heart disease.  Dr. Sommer also directs the Left Atrial Appendage Closure program, a rapidly growing procedure designed to reduce stroke and to eliminate the need for long term oral anticoagulant blood thinners in patients with atrial fibrillation.

Dr. Sommer is actively involved in a number of cutting edge clinical research protocols in congenital and structural heart disease. He is the National Co-Principal Investigator for the ASSURED Trial (the testing of a new device to close atrial septal defects). He is the local principal investigator for the COMPASSION 3 Trial (assessing the effectiveness of a new catheter implantable valve for pulmonary valve replacement), and for the REDUCE PFO Trial (studying the effect of PFO closure on stroke prevention). He is the local principal investigator for the AMULET Trial (studying a new device for stroke prevention in patients with atrial fibrillation). He has recently completed groundbreaking research on the role of platelets in the migraine headache patient population who have a patent foramen ovale, which has been submitted for publication. The research included the TRACTOR Migraine Headache Trial, assessing the impact of ticagrelor on migraine headache symptoms in patients with patent foramen ovale. That data has led to the development of a new National Migraine-PFO trial to begin in 2018, in association with leaders of the migraine headache neurology community. Previous research included the REDUCE-LAP Trial (a novel catheter-based intervention for patients with congestive heart failure and preserved ventricular systolic function).

Previously, Dr. Sommer was the National Principal Investigator of the ESCAPE Migraine PFO Trial, the local Principal Investigator for the CLOSURE I PFO trials, the local PI for the PREVAIL Left Atrial Appendage Closure Trial, and the National PI for the trial of the CARDIOX Shunt detection system.

Hospital Affiliations

  • NewYork-Presbyterian/Lawrence Hospital
  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Morgan Stanley Children's Hospital

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-342-0886

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • New York University School of Medicine
  • Residency: Mount Sinai Hospital
  • Fellowship: Mount Sinai Hospital
  • Fellowship: Boston Children's Hospital

Board Certifications

  • Pediatric Cardiology
  • Pediatrics

Honors & Awards

Best Doctors in New York (Castle Connelly – NY Magazine) 2001-4, 2006-8, 2011
Best Doctors New York Metro Area (Castle Connelly)  2005-16
Best Doctors in America (Castle Connelly)   2006-16
Patients’ Choice Award (Castle Connelly)   2010-16
Compassionate Doctor Award (Castle Connelly)   2013-15
Rotary Club/Gift of Life – Humanitarian Award   2008
SCARC Guardianship Services – Distinguished Services Award for Exceptional and Compassionate Care  2008
New York Family Magazine – Top Pediatrician   2008

America's Top Doctor
NY Top Doctor

Research

Grants

AMPLATZER AMULET LEFT ATRIAL APPENDAGE OCCLUDER RANDOMIZED CONTROLLED TRIAL (P&S Industry Clinical Trial)

Jul 6 2017 - Jul 6 2022

GORE? CARDIOFORM ASD OCCLUDER CLINICAL STUDY: A STUDY TO EVALUATE SAFETY AND EFFICACY IN THE TREATMENT OF TRANSCATHETER CLOSURE OF OSTIUM SECUNDUM ATRIAL SEPTAL DEFECTS (ASDS) (P&S Industry Clinical Trial)

May 16 2017 - May 16 2022

FDS-0005 CONTROLLED, WITHIN SUBJECT COMPARISON OF CARDIOX FDS TECHNOLOGY TO TRANSESOPHAGEAL ECHOCARDIOGRAPHY (TEE) AND CARDIOX FDS TECHNOLOGY TO TRANSCRANIAL DOPPLER (TCD) FOR THE DETECTION OF RIGHT-TO-LEFT SHUNTS (P&S Industry Clinical Trial)

Mar 13 2013 - Mar 13 2018

PIVOTAL-CARDIOX (P&S Industry Clinical Trial)

Oct 28 2011 - Oct 28 2016

PREVAIL (P&S Industry Clinical Trial)

Aug 8 2011 - Aug 18 2016

HYPOXEMIA TRIAL: A TWO CENTER, OPEN LABEL, FEASIBILITY STUDY TO ASSESS THE IMPACT OF PATENT FORAMEN OVALE CLOSURE (P&S Industry Clinical Trial)

Mar 12 2010 - Mar 12 2015

CARDIOX STUDY: CARDIOX SHUNT DETECTION TECHNOLOGY FEASIBILITY (P&S Industry Clinical Trial)

Aug 27 2009 - Aug 27 2014